跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
TRUQAP
Authorized
STANDARD
TRUQAP
astrazeneca canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7af01f2bd4c4b7a2
Company
astrazeneca canada inc
Type
Standard
Approval Details
Approval Id
7af01f2bd4c4b7a2
Drug Approval Canada Name
TRUQAP
Product Name
TRUQAP
Status
Marketed
Status Date
2024-04-01
Original Market Date
2024-04-01
Din
02544741
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EX27 CAPIVASERTIB
Atc Name
l 01 ex 27
Aig Number
0165703002
Company Name
astrazeneca canada inc
Company Address
1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4
Active Ingredients
CAPIVASERTIB
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7af01f2bd4c4b7a2
Type
Standard
Back to Health Canada Approvals
TRUQAP - Health Canada Drug Approval Details